Predicting Abdominal Reoperation

Predicting Long-term Risk of Reoperations Following Abdominal and Pelvic Surgery: a Nationwide Retrospective Cohort Study

Nationwide retrospective study, to predict the risk of abdominal reoperation.

Study Overview

• Status: Completed
• Conditions: Surgery; Abdominal Adhesion

• Study Type: Observational
• Enrollment (Actual): 72270

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

All patients undergoing first abdominal or pelvic surgery between June 1st 2009 and June 30th 2011 in Scotland.

Description

Inclusion Criteria:

• All patients undergoing first abdominal or pelvic surgery between June 1st 2009 and June 30th 2011 in Scotland.

Exclusion Criteria:

• Positive history for abdominal surgery

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Retrospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Patients with first abdominal surgery in Scotland between 2009 and 2011

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of patients with an abdominal reoperation in the study cohort	Number of patients undergoing a reoperation after abdominal surgery	within 5 years postoperatively

Collaborators and Investigators

• Sponsor: Radboud University Medical Center
• Collaborators: NHS Research Scotland

Study record dates

Study Major Dates

• Study Start (Actual): June 1, 2009
• Primary Completion (Actual): December 1, 2018
• Study Completion (Actual): August 1, 2022

Study Registration Dates

• First Submitted: August 17, 2022
• First Submitted That Met QC Criteria: August 24, 2022
• First Posted (Actual): August 25, 2022

Study Record Updates

• Last Update Posted (Actual): August 25, 2022
• Last Update Submitted That Met QC Criteria: August 24, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Fibrosis; Cicatrix; Tissue Adhesions
• Other Study ID Numbers: SCARreop

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

IPD Plan Description

The data that support the findings of this study are available from the Scottish National Health Service (NHS). Restrictions apply to the availability of these data, which were used under license for this study. Data derived from the analysis are available from the authors with the permission of the Scottish NHS.

The used repository was the Safe Haven (https://shs.epcc.ed.ac.uk/2fa/scotnsh.html) from the NHS.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No